| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/07/1998 | WO1997046712A3 System and method for carrying out and monitoring biological processes |
| 05/07/1998 | WO1997046683A3 Polynucleotides encoding secreted proteins |
| 05/07/1998 | WO1997045543A3 Cc chemokine receptor 5, antibodies thereto, transgenic animals |
| 05/07/1998 | WO1997045542A3 Cell growth regulatory genes |
| 05/07/1998 | WO1997044461A3 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/07/1998 | WO1997040193A3 Method for typing and detecting hbv |
| 05/07/1998 | DE19654946A1 Detecting fungi resistant to azole antimycotics in clinical samples |
| 05/07/1998 | CA2665133A1 Neutrokine .alpha. |
| 05/07/1998 | CA2535449A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 05/07/1998 | CA2271720A1 Streptococcus pneumoniae polynucleotides and sequences |
| 05/07/1998 | CA2270901A1 Delivery construct for antisense nucleic acids and methods of use |
| 05/07/1998 | CA2270412A1 High level of expression of ingap |
| 05/07/1998 | CA2270345A1 Immunostimulatory nucleic acid molecules |
| 05/07/1998 | CA2269865A1 Process aimed at evidencing the state of a malignant cell and process for treatment |
| 05/07/1998 | CA2269802A1 Nucleic acid sequence encoding beta-c-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin |
| 05/07/1998 | CA2269801A1 Stable expression of triple helical proteins |
| 05/07/1998 | CA2269800A1 Microbial preparation of substances from aromatic metabolism/i |
| 05/07/1998 | CA2269744A1 Proteome analysis for characterization of up- and down-regulated proteins in biological samples |
| 05/07/1998 | CA2269738A1 Targeted cytolysis of cancer cells |
| 05/07/1998 | CA2269722A1 Oligomers which inhibit the expression of interleukin genes |
| 05/07/1998 | CA2269663A1 Streptococcus pneumoniae antigens and vaccines |
| 05/07/1998 | CA2269642A1 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids |
| 05/07/1998 | CA2269635A1 Protease-activated receptor 3 and uses thereof |
| 05/07/1998 | CA2269633A1 Candida albicans proteins associated with virulence and hyphal formation and uses thereof |
| 05/07/1998 | CA2269213A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna |
| 05/07/1998 | CA2269094A1 Process and composition for preparing d-aspartic acid |
| 05/07/1998 | CA2268869A1 Method for preparing 2-hydroxy 4-methylthio butyric acid using a nitrilase |
| 05/07/1998 | CA2268750A1 Human p2x purinoreceptor |
| 05/07/1998 | CA2268745A1 Flax promoters for manipulating gene expression |
| 05/07/1998 | CA2268263A1 Plant cellulose synthase and promoter sequences |
| 05/07/1998 | CA2268027A1 Novel flt-3 receptor agonists |
| 05/07/1998 | CA2268023A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
| 05/07/1998 | CA2268001A1 Circularly permuted erythropoietin receptor agonists |
| 05/07/1998 | CA2267996A1 Novel pesticidal toxins and nucleotide sequences which encode these toxins |
| 05/07/1998 | CA2265523A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
| 05/07/1998 | CA2241855A1 Chromosomal markers and diagnostic tests for manic-depressive illness |
| 05/07/1998 | CA2241626A1 Riboflavin mutants as vaccines against actinobacillus pleuropneumoniae |
| 05/07/1998 | CA2241173A1 Cdna fragment of causative gene of spinocerebellar ataxia type 2 |
| 05/06/1998 | EP0839917A1 Primer and probes for the detection of HIV |
| 05/06/1998 | EP0839915A1 Secretory immunoglobulin A as a mucosal vaccine delivery system |
| 05/06/1998 | EP0839914A1 PROCESS FOR MODIFYING THE ENZYME 7 beta-(4-CARBOXYBUTANAMIDO) CEPHALOSPORINACYLASE AND PURIFYING SAID ENZYME IN A SINGLE CHROMATOGRAPHIC STEP |
| 05/06/1998 | EP0839913A2 DNA-Based vaccination of fish by immersion |
| 05/06/1998 | EP0839912A1 Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 05/06/1998 | EP0839911A1 Method for identifying attenuated chickenpox virus oka strain or strain originating therein and acceptable as attenuated chickenpox vaccine virus |
| 05/06/1998 | EP0839910A2 Spo-rel, a Staphylococcus relA/spot homologue |
| 05/06/1998 | EP0839909A1 Nucleic acid sequences encoding citrate transporter proteins |
| 05/06/1998 | EP0839908A2 A novel human ETS family member, ELF3 |
| 05/06/1998 | EP0839831A2 Single chain gonadotropin |
| 05/06/1998 | EP0839830A1 Polyether nucleic acids |
| 05/06/1998 | EP0839536A1 Methods and compositions for promoting immunopotentiation |
| 05/06/1998 | EP0839214A1 Method for identifying and/or quantifying expression of nucleic acid molecules in a sample |
| 05/06/1998 | EP0839212A1 A method and system for sequencing genomes |
| 05/06/1998 | EP0839211A1 Riboflavin-production process by means of micro-organisms with modified isocitratlyase activity |
| 05/06/1998 | EP0839208A1 A method for promoting enzyme diversity |
| 05/06/1998 | EP0839207A2 p16 EXPRESSION CONSTRUCTS AND THEIR APPLICATION IN CANCER THERAPY |
| 05/06/1998 | EP0839206A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 05/06/1998 | EP0839205A1 Liver-specific adenovirus expression vector |
| 05/06/1998 | EP0839204A2 Method for producing haemin proteins using plant cells, resulting proteins and products containing same |
| 05/06/1998 | EP0839203A1 Inhibition of gene expression |
| 05/06/1998 | EP0839202A2 Inhibition of gene expression |
| 05/06/1998 | EP0839201A1 Cathepsin-l, the pre-proform thereof and the corresponding propeptide from ciliates |
| 05/06/1998 | EP0839200A1 Leucine aminopeptidases produced recombinantly from aspergillus soyae |
| 05/06/1998 | EP0839199A1 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 05/06/1998 | EP0839198A1 Surface anchoring vector and system for foreign proteins thereof |
| 05/06/1998 | EP0839197A2 MODIFIED HUMAN CHORIONIC ($g(b)-hCG) PROTEINS AND THEIR MEDICAL USE |
| 05/06/1998 | EP0839196A2 Human ctla-8 and uses of ctla-8-related proteins |
| 05/06/1998 | EP0839195A1 Nucleotide and peptide sequences for treating myasthenia |
| 05/06/1998 | EP0839194A1 Protein p53 variants and their therapeutic uses |
| 05/06/1998 | EP0839193A2 Porphyrin-accumulating type herbicide resistance gene |
| 05/06/1998 | EP0839189A1 Enzymes and microorganisms having amidase activity for hydrolysing polyamides |
| 05/06/1998 | EP0839188A1 Enzymes and micro-organisms with amidase activity which hydrolyse polyamides |
| 05/06/1998 | EP0839186A1 A modified enzyme with lipolytic activity |
| 05/06/1998 | EP0839185A1 Screening methods for enzymes and enzyme kits |
| 05/06/1998 | EP0839184A1 Synthetic hpv11 virus-like particles |
| 05/06/1998 | EP0839183A1 Immortalized epithelial tumor cell |
| 05/06/1998 | EP0839156A1 Anti-fungal peptides |
| 05/06/1998 | EP0839125A1 Novel cationic lipids and the use thereof |
| 05/06/1998 | EP0839055A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
| 05/06/1998 | EP0839054A1 Tumor- or cell-specific herpes simplex virus replication |
| 05/06/1998 | EP0839045A1 Interleukin-1 receptor-associated protein kinase and assays |
| 05/06/1998 | EP0839006A1 Process for stabilizing proteins in an acidic environment with a high-ester pectin |
| 05/06/1998 | EP0838999A2 Insect control with multiple toxins |
| 05/06/1998 | EP0817849A4 Genetic sequences conferring nematode resistance in plants and uses therefor |
| 05/06/1998 | EP0788364A4 Treatment of urogenital cancer with boron neutron capture therapy |
| 05/06/1998 | EP0785999A4 Plant transcription regulators from circovirus |
| 05/06/1998 | EP0742790A4 Substituted purines and oligonucleotide cross-linking |
| 05/06/1998 | EP0727046A4 Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease |
| 05/06/1998 | EP0723549A4 Nucleic acid purification compositions and methods |
| 05/06/1998 | EP0711355A4 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 05/06/1998 | EP0702727A4 Dyes designed for high sensitivity detection of double-stranded dna |
| 05/06/1998 | EP0673418B1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| 05/06/1998 | CN1181110A 成纤维细胞生长因子11 Fibroblast Growth Factor 11 |
| 05/06/1998 | CN1181109A Transforming growth factor 'alpha'-HII |
| 05/06/1998 | CN1181108A Psychrophilic protease and psychrophilic bacteria |
| 05/06/1998 | CN1181021A Method and compositions for regulation of CD28 expression |
| 05/06/1998 | CN1181020A Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation mthod therefor and pharmaceutical compositions containing same |
| 05/06/1998 | CN1180746A Method for inducing plant tissue gene transfer by ultrasonic wave |
| 05/06/1998 | CN1180745A New carrier for gene treatment |
| 05/06/1998 | CN1180709A Neopolynucleotide and polypeptide gene of genetic multiple exogenetic bone wart family |
| 05/06/1998 | CN1180697A Cationic lipids for gene therapy |